Non-Psychosis Symptoms of Clozapine Withdrawal: a Systematic Review
East Asian Archives of Psychiatry · 2023
DOI: 10.12809/eaap2261 ↗At a glance
Systematische Übersicht in East Asian Archives of Psychiatry, 2023. Written by B Yee and 5 co-authors. Institution: Department of Medicine, College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia. Major MEDLINE topics: Antipsychotic Agents, Catatonia, Clozapine, Schizophrenia. Cited 13 times so far (Crossref). The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
OBJECTIVE: Clozapine is a potent antipsychotic medication with a complex receptor profile. It is reserved for treatment-resistant schizophrenia. We systematically reviewed studies of non-psychosis symptoms of clozapine withdrawal. METHODS: CINAHL, Medline, PsycINFO, PubMed, and the Cochrane Database of Systematic Reviews were searched using the keywords 'clozapine,' and 'withdrawal,' or 'supersensitivity,' 'cessation,' 'rebound,' or 'discontinuation'. Studies related to non-psychosis symptoms after clozapine withdrawal were included. RESULTS: Five original studies and 63 case reports / series were included in analysis. In 195 patients included in the five original studies, approximately 20% experienced non-psychosis symptoms following discontinuation of clozapine. In 89 patients in four of the studies, 27 experienced cholinergic rebound, 13 exhibited extrapyramidal symptoms (including tardive dyskinesia), and three had catatonia. In 63 case reports / series included, 72 patients with non-psychosis symptoms were reported, which were catatonia (n=30), dystonia or dyskinesia (n=17), cholinergic rebound (n=11), serotonin syndrome (n=4), mania (n=3), insomnia (n=3), neuroleptic malignant syndrome (NMS) [n=3, one of them had both catatonia and NMS], and de novo obsessive compulsive symptoms (n=2). Restarting clozapine appeared to be the most effective treatment. CONCLUSIONS: Non-psychosis symptoms following clozapine withdrawal have important clinical implications. Clinicians should be aware of the possible presentations of symptoms to ensure early recognition and management. Further research is warranted to better characterise the prevalence, risk factors, prognosis, and optimal drug dosing for each withdrawal symptom.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Medicine, College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.
- Academic Unit of Psychiatry and Addiction Medicine, The Australian National University School of Medicine and Psychology, Canberra Hospital, Canberra, Australian Capital Territory, Australia.
- Department of Psychiatry, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
- Department of Psychiatry, Monash University, Melbourne, Victoria, Australia.
Cite
APA
Yee, B., Looi, J. C. L., Agaciak, M., Allison, S., Chan, S. K. W., & Bastiampillai, T. (2023). Non-Psychosis Symptoms of Clozapine Withdrawal: a Systematic Review. East Asian Archives of Psychiatry. https://doi.org/10.12809/eaap2261
Vancouver
Yee B, Looi JCL, Agaciak M, Allison S, Chan SKW, Bastiampillai T. Non-Psychosis Symptoms of Clozapine Withdrawal: a Systematic Review. East Asian Archives of Psychiatry. 2023. doi:10.12809/eaap2261
BibTeX
@article{Yee2023,
author = {Yee, B and Looi, J C L and Agaciak, M and Allison, S and Chan, S K W and Bastiampillai, T},
title = {Non-Psychosis Symptoms of Clozapine Withdrawal: a Systematic Review},
journal = {East Asian Archives of Psychiatry},
year = {2023},
doi = {10.12809/eaap2261}
}
EUVIMED